GlassScriptPhysician profile
Joseph J Logan
NPI 1841203775
$551.56
in general payments reported to CMS, 2019-2025
10 companies · $57.77 in 2025
The $57.77 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $83.04 · 2021: $42.85 · 2022: $73.56 · 2023: $47.59 · 2024: $99.56 · 2025: $57.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $175 · Education: $30.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $174.83 |
| Education | $30.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $146.07 | 2019-2024 | Trulance |
| Abbvie INC. | $111.41 | 2019-2021 | |
| Janssen Biotech, INC. | $82.04 | 2020-2025 | Tremfya, Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $67.01 | 2022-2025 | Entyvio |
| Merck Sharp & Dohme LLC | $43.01 | 2019-2021 | |
| Celltrion USA INC. | $30.09 | 2023-2024 | Zymfentra, Yuflyma |
| Angiodynamics, INC. | $20.50 | 2023 | Angiodynamics |
| Regeneron Healthcare Solutions, INC. | $18.72 | 2024 | Dupixent |
| Lilly USA, LLC | $16.89 | 2024 | Omvoh |
| Pacira Pharmaceuticals Incorporated | $15.82 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Logan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.